Search for: "Actavis Pharma"
Results 201 - 220
of 243
Sorted by Relevance
|
Sort by Date
13 Apr 2015, 12:50 pm
| Oprah Winfrey and OWN YOUR POWER trade mark | EPO December Administrative Council Meeting | Blurred Lines | Again on Actavis v Boehringer | Is the EU Patent Package diminishing the EU’s powers? [read post]
22 Jun 2018, 3:18 am
Actavis | Can YouTube be primarily liable for users' infringements? [read post]
14 Jul 2021, 1:04 am
"Sufficiency of medical use claims in other jurisdictionsUntested hypothesis in a clinical trial protocol destroys novelty of a method of treatment claim in Australia (Mylan v Sun Pharma)Canadian Federal Court considers whether Teva's COPAXONE second medical use patents were obvious-to-try (Teva v Pharmascience) [read post]
30 Apr 2019, 5:29 am
This focused on the three-step test of the Eli Lilly v Actavis UK Supreme Court decision and the subsequent UK cases applying that test. [read post]
12 Nov 2014, 10:15 am
Janssen and Teva file to protect Chicago disclosing trade secrets: Back in the summer, the city of Chicago commenced proceedings against several pharmaceutical companies, including Janssen, Purdue Pharma LP, Teva and Actavis alleging that they dishonestly marketed opioid painkillers including Oxycontin and Percocet for the treatment of common and non-cancer related chronic pain resulting in a reported public health crisis of addiction and abuse. [read post]
12 Oct 2015, 12:11 pm
| IP: When innovation is the answer to a spiritual funk Never Too Late 63 [week ending on Sunday 13 September] - Fair compensation in reprography and private copying: the ECS’ version | Substitute sellers | Teva UK Ltd & Another v Leo Pharma | Evidence-based IP policy | KitKat case | UK IPO’s priorities | UK IPO’s… [read post]
9 May 2017, 12:59 pm
This week she brings readers the parts of Pharma, IP & Competition, The sun rises on plausibility, but where (and when) will it set? [read post]
7 Jul 2015, 1:58 am
China-watcher and a former occasional contributor to this weblog Tom Carver leads the session on enforcing pharma patents in that vast, imponderable jurisdiction. [read post]
27 Apr 2015, 10:56 am
It has been all quiet on the pharma patent front since the beginning of March (when the epic series of first instance decisions on Swiss form claims came to and end: see here, here, here and here), and so this moggy was delighted when there fell into his paws the decision of Mr Justice Arnold in Novartis v Focus, Actavis, Teva [2015] EWHC 1068 (Pat).The case concerns a transdermal patch for rivastigmine, which is acetylcholinesterase (AChE) inhibitor used in the treatment… [read post]
12 Jun 2017, 1:00 am
Reverse payments to delay generic market entry are judged post-Actavis under the “rule of reason”. [read post]
5 Oct 2015, 5:13 am
| IP: When innovation is the answer to a spiritual funkNever Too Late 63 [week ending on Sunday 13 September] - Fair compensation in reprography and private copying: the ECS’ version | Substitute sellers | Teva UK Ltd & Another v Leo Pharma | Evidence-based IP policy | KitKat case | UK IPO’s priorities | UK IPO’s website vs complete copyright legislation | Patent Attorney Qualifications | Mylan and Actavis v… [read post]
20 Sep 2015, 4:08 pm
******************PREVIOUSLY, ON NEVER TOO LATE Never Too Late 63 [week ending on Sunday 13 September] - Fair compensation in reprography and private copying: the ECS’ version | Substitute sellers | Teva UK Ltd & Another v Leo Pharma | Evidence-based IP policy | KitKat case | UK IPO’s priorities | UK IPO’s website vs complete copyright legislation | Patent Attorney Qualifications | Mylan and Actavis v… [read post]
25 Jun 2018, 7:15 am
Actavis | Can YouTube be primarily liable for users' infringements? [read post]
4 Jun 2018, 3:02 am
Actavis | Can YouTube be primarily liable for users' infringements? [read post]
3 May 2015, 10:33 pm
With this note, he provides further food for thought on patent law’s complexity, from Bilski to Teva v Leo Pharma, to the relation between patent law and economics. [read post]
28 Sep 2015, 3:35 am
| IP: When innovation is the answer to a spiritual funkNever Too Late 63 [week ending on Sunday 13 September] - Fair compensation in reprography and private copying: the ECS’ version | Substitute sellers | Teva UK Ltd & Another v Leo Pharma | Evidence-based IP policy | KitKat case | UK IPO’s priorities | UK IPO’s website vs complete copyright legislation | Patent Attorney Qualifications | Mylan and Actavis v… [read post]
2 Feb 2015, 2:20 am
Not only did the Dutch Court disagree with the Courts of England and Wales on the matter of priority entitlement and hence validity , but also this ruling appears to be in contrast to the case last week [for which see Katpost here for the first instance and here and here for the appeal judgment] where Arnold J permitted Actavis to launch a product with a skinny label without requiring further measures such as… [read post]
25 Sep 2015, 8:17 am
Chem/pharma: no explosion, not much failure to bargain. [read post]
27 Nov 2018, 3:19 am
| Special interview with Mariana Karepova, the President of the Austrian Patent Office | ChIPs Global Summit Report 1: Politics and Technology - When D.C. met Silicon Valley | Book review: Kritika - Essays on Intellectual Property (vol 3) | Tuesday TiddlywinksNever Too Late 202 [Week ending 7 October] Looking to discuss the latest developments in competition law in the pharma sector? [read post]
7 Oct 2019, 11:12 am
IP Enforcement GuestKat Peter Ling, in‘There is No Such Thing as a Free Launch – CJEU Does Not Follow AG on Compensation for Wrongful PI' , reports and critically comments on the latest ruling in Bayer Pharma case C-688/17. [read post]
